Efficacy of To Be Marketed (TBM) Cholic Acid Capsules Used to Treat Children With Inborn Errors of Bile Acid Synthesis
Clinical trial NCT01115582 · COMPLETED
Trial details
- NCT number
- NCT01115582
- Sponsor
- Mirum Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-04-01
- Primary completion
- 2010-08-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.